Hanwha Q Cells Co. Ltd. (NASDAQ:HQCL) was upgraded by Zacks Investment Research from a “hold” rating to a “buy” rating in a report issued on Tuesday. The brokerage presently has a $9.25 price target on the stock. Zacks Investment Research’s target price would indicate a potential upside of 13.78% from the company’s current price.

According to Zacks, “Hanwha Q CELLS Co., Ltd. is a photovoltaic manufacturer for solar cells and modules. The company offers the full spectrum of photovoltaic products, applications and solutions, from modules to kits to systems to large scale solar power plants. It operates primarily in Europe, North America, Asia, South America, Africa and the Middle East. Hanwha Q CELLS Co. Ltd., formerly known as Hanwha SolarOne Co. Ltd., is headquartered in Seoul, South Korea. “

Separately, Roth Capital lowered shares of Hanwha Q Cells Co. from a “buy” rating to a “neutral” rating in a research note on Friday, August 5th.

Shares of Hanwha Q Cells Co. (NASDAQ:HQCL) opened at 8.13 on Tuesday. The company’s 50-day moving average is $0.00 and its 200 day moving average is $0.00.

Hanwha Q Cells Co. (NASDAQ:HQCL) last issued its earnings results on Tuesday, November 22nd. The company reported $0.50 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.21 by $0.29. The business had revenue of $707.80 million for the quarter, compared to analyst estimates of $653.40 million. Hanwha Q Cells Co. had a net margin of 6.73% and a return on equity of 42.02%. The business’s revenue for the quarter was up 65.7% on a year-over-year basis. Analysts anticipate that Hanwha Q Cells Co. will post $1.67 earnings per share for the current fiscal year.

ILLEGAL ACTIVITY WARNING: “Hanwha Q Cells Co. Ltd. (HQCL) Stock Rating Upgraded by Zacks Investment Research” was originally published by The Cerbat Gem and is owned by of The Cerbat Gem. If you are accessing this story on another site, it was illegally copied and reposted in violation of United States & international copyright & trademark laws. The original version of this story can be read at https://www.thecerbatgem.com/2016/12/01/hanwha-q-cells-co-ltd-hqcl-stock-rating-upgraded-by-zacks-investment-research.html.

Several large investors have recently made changes to their positions in the stock. Guggenheim Capital LLC increased its stake in shares of Hanwha Q Cells Co. by 27.8% in the second quarter. Guggenheim Capital LLC now owns 493,596 shares of the company’s stock worth $7,108,000 after buying an additional 107,408 shares in the last quarter. Barclays PLC acquired a new stake in shares of Hanwha Q Cells Co. during the first quarter worth $432,000. Oxford Asset Management acquired a new stake in shares of Hanwha Q Cells Co. during the second quarter worth $392,000. Morgan Stanley increased its stake in shares of Hanwha Q Cells Co. by 12.8% in the third quarter. Morgan Stanley now owns 181,537 shares of the company’s stock worth $2,035,000 after buying an additional 20,545 shares in the last quarter. Finally, AJO LP acquired a new stake in shares of Hanwha Q Cells Co. during the second quarter worth $171,000. 1.29% of the stock is owned by institutional investors and hedge funds.

About Hanwha Q Cells Co.

Hanwha Q CELLS Co, Ltd., formerly Hanwha SolarOne Co, Ltd., is a global solar energy company engaged in the manufacturing of solar modules, and the development and management of downstream solar farms. It manufactures a range of photo voltaic (PV) cells and PV modules at its manufacturing facilities in China and Malaysia using manufacturing process technologies, including those developed at its research and development facilities in Germany.

5 Day Chart for NASDAQ:HQCL

Receive News & Stock Ratings for Hanwha Q Cells Co. Ltd. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Hanwha Q Cells Co. Ltd. and related stocks with our FREE daily email newsletter.